MXCT – maxcyte, inc. (US:NASDAQ)
Stock Stats
News
Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPO [Yahoo! Finance]
Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPO
MaxCyte (NASDAQ:MXCT) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
MaxCyte (NASDAQ:MXCT) was upgraded by analysts at Wall Street Zen fr
MaxCyte (NASDAQ:MXCT) was upgraded by analysts at Wall Street Zen fr
Form SCHEDULE 13G/A MAXCYTE, INC. Filed by: CADIAN CAPITAL MANAGEMENT, LP
Form 8-K MAXCYTE, INC. For: Nov 12
Form 8-K MAXCYTE, INC. For: Nov 05
Form SCHEDULE 13G/A MAXCYTE, INC. Filed by: MIRABELLA FINANCIAL SERVICES LLP
Form SCHEDULE 13G MAXCYTE, INC. Filed by: MIRABELLA FINANCIAL SERVICES LLP
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.